A hospital-wide intervention replacing ceftriaxone with cefotaxime to reduce rate of healthcare-associated infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in the intensive care unit

Intensive Care Med. 2018 May;44(5):672-673. doi: 10.1007/s00134-018-5079-y. Epub 2018 Feb 2.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Cefotaxime / therapeutic use
  • Ceftriaxone / therapeutic use
  • Cross Infection* / prevention & control
  • Enterobacteriaceae
  • Enterobacteriaceae Infections* / drug therapy
  • Humans
  • Intensive Care Units
  • Microbial Sensitivity Tests
  • beta-Lactamases / pharmacology

Substances

  • Anti-Bacterial Agents
  • Ceftriaxone
  • beta-Lactamases
  • Cefotaxime